Branded Versus Generic Antiepileptic Drugs in Epilepsy: Weighing Clinical Impact and Cost Effectiveness
International Journal of Pharmaceutical Investigation · 11.06.2026 · 16 (3) · 946-952
DOI: 10.5530/ijpi.20260550 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Investigation, online erschienen am 11.06.2026. Verfasst von Sandeep Kumar Yadav und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yadav, S. K., Kini, P. N., Kusnoor, A., Mulla, M., Karoli, S., & Gudhoor, M. (2026). Branded Versus Generic Antiepileptic Drugs in Epilepsy: Weighing Clinical Impact and Cost Effectiveness. International Journal of Pharmaceutical Investigation, 16(3), 946-952. https://doi.org/10.5530/ijpi.20260550
Vancouver
Yadav SK, Kini PN, Kusnoor A, Mulla M, Karoli S, Gudhoor M. Branded Versus Generic Antiepileptic Drugs in Epilepsy: Weighing Clinical Impact and Cost Effectiveness. International Journal of Pharmaceutical Investigation. 2026;16(3):946-952. doi:10.5530/ijpi.20260550
BibTeX
@article{Yadav2026,
author = {Yadav, Sandeep Kumar and Kini, Pratiksha Nagesh and Kusnoor, AnilKumar and Mulla, Mujammil and Karoli, Satish and Gudhoor, Manjula},
title = {Branded Versus Generic Antiepileptic Drugs in Epilepsy: Weighing Clinical Impact and Cost Effectiveness},
journal = {International Journal of Pharmaceutical Investigation},
year = {2026},
volume = {16},
number = {3},
pages = {946--952},
doi = {10.5530/ijpi.20260550}
}
EUVIMED